2024-11-012025-10-312025-10-31false11634394CONSILIUM SCIENTIFIC2025-11-2786900falseiso4217:GBPxbrli:pure116343942024-10-31116343942025-10-31116343942024-11-012025-10-31116343942023-10-31116343942024-10-31116343942023-11-012024-10-3111634394bus:SmallEntities2024-11-012025-10-3111634394bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3111634394bus:FullAccounts2024-11-012025-10-3111634394bus:CompanyLimitedByGuarantee2024-11-012025-10-3111634394core:WithinOneYear2025-10-3111634394core:AfterOneYear2025-10-3111634394core:WithinOneYear2024-10-3111634394core:AfterOneYear2024-10-3111634394core:ShareCapital2025-10-3111634394core:SharePremium2025-10-3111634394core:RevaluationReserve2025-10-3111634394core:OtherReservesSubtotal2025-10-3111634394core:RetainedEarningsAccumulatedLosses2025-10-3111634394core:ShareCapital2024-10-3111634394core:SharePremium2024-10-3111634394core:RevaluationReserve2024-10-3111634394core:OtherReservesSubtotal2024-10-3111634394core:RetainedEarningsAccumulatedLosses2024-10-3111634394core:LandBuildings2025-10-3111634394core:PlantMachinery2025-10-3111634394core:Vehicles2025-10-3111634394core:FurnitureFittings2025-10-3111634394core:OfficeEquipment2025-10-3111634394core:NetGoodwill2025-10-3111634394core:IntangibleAssetsOtherThanGoodwill2025-10-3111634394core:ListedExchangeTraded2025-10-3111634394core:UnlistedNon-exchangeTraded2025-10-3111634394core:LandBuildings2024-10-3111634394core:PlantMachinery2024-10-3111634394core:Vehicles2024-10-3111634394core:FurnitureFittings2024-10-3111634394core:OfficeEquipment2024-10-3111634394core:NetGoodwill2024-10-3111634394core:IntangibleAssetsOtherThanGoodwill2024-10-3111634394core:ListedExchangeTraded2024-10-3111634394core:UnlistedNon-exchangeTraded2024-10-3111634394core:LandBuildings2024-11-012025-10-3111634394core:PlantMachinery2024-11-012025-10-3111634394core:Vehicles2024-11-012025-10-3111634394core:FurnitureFittings2024-11-012025-10-3111634394core:OfficeEquipment2024-11-012025-10-3111634394core:NetGoodwill2024-11-012025-10-3111634394core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3111634394core:ListedExchangeTraded2024-11-012025-10-3111634394core:UnlistedNon-exchangeTraded2024-11-012025-10-3111634394core:MoreThanFiveYears2024-11-012025-10-3111634394core:Non-currentFinancialInstruments2025-10-3111634394core:Non-currentFinancialInstruments2024-10-3111634394dpl:CostSales2024-11-012025-10-3111634394dpl:DistributionCosts2024-11-012025-10-3111634394core:LandBuildings2024-11-012025-10-3111634394core:PlantMachinery2024-11-012025-10-3111634394core:Vehicles2024-11-012025-10-3111634394core:FurnitureFittings2024-11-012025-10-3111634394core:OfficeEquipment2024-11-012025-10-3111634394dpl:AdministrativeExpenses2024-11-012025-10-3111634394core:NetGoodwill2024-11-012025-10-3111634394core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3111634394dpl:GroupUndertakings2024-11-012025-10-3111634394dpl:ParticipatingInterests2024-11-012025-10-3111634394dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3111634394core:ListedExchangeTraded2024-11-012025-10-3111634394dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3111634394core:UnlistedNon-exchangeTraded2024-11-012025-10-3111634394dpl:CostSales2023-11-012024-10-3111634394dpl:DistributionCosts2023-11-012024-10-3111634394core:LandBuildings2023-11-012024-10-3111634394core:PlantMachinery2023-11-012024-10-3111634394core:Vehicles2023-11-012024-10-3111634394core:FurnitureFittings2023-11-012024-10-3111634394core:OfficeEquipment2023-11-012024-10-3111634394dpl:AdministrativeExpenses2023-11-012024-10-3111634394core:NetGoodwill2023-11-012024-10-3111634394core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3111634394dpl:GroupUndertakings2023-11-012024-10-3111634394dpl:ParticipatingInterests2023-11-012024-10-3111634394dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3111634394core:ListedExchangeTraded2023-11-012024-10-3111634394dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3111634394core:UnlistedNon-exchangeTraded2023-11-012024-10-3111634394core:NetGoodwill2025-10-3111634394core:IntangibleAssetsOtherThanGoodwill2025-10-3111634394core:LandBuildings2025-10-3111634394core:PlantMachinery2025-10-3111634394core:Vehicles2025-10-3111634394core:FurnitureFittings2025-10-3111634394core:OfficeEquipment2025-10-3111634394core:AfterOneYear2025-10-3111634394core:WithinOneYear2025-10-3111634394core:ListedExchangeTraded2025-10-3111634394core:UnlistedNon-exchangeTraded2025-10-3111634394core:ShareCapital2025-10-3111634394core:SharePremium2025-10-3111634394core:RevaluationReserve2025-10-3111634394core:OtherReservesSubtotal2025-10-3111634394core:RetainedEarningsAccumulatedLosses2025-10-3111634394core:NetGoodwill2024-10-3111634394core:IntangibleAssetsOtherThanGoodwill2024-10-3111634394core:LandBuildings2024-10-3111634394core:PlantMachinery2024-10-3111634394core:Vehicles2024-10-3111634394core:FurnitureFittings2024-10-3111634394core:OfficeEquipment2024-10-3111634394core:AfterOneYear2024-10-3111634394core:WithinOneYear2024-10-3111634394core:ListedExchangeTraded2024-10-3111634394core:UnlistedNon-exchangeTraded2024-10-3111634394core:ShareCapital2024-10-3111634394core:SharePremium2024-10-3111634394core:RevaluationReserve2024-10-3111634394core:OtherReservesSubtotal2024-10-3111634394core:RetainedEarningsAccumulatedLosses2024-10-3111634394core:NetGoodwill2023-10-3111634394core:IntangibleAssetsOtherThanGoodwill2023-10-3111634394core:LandBuildings2023-10-3111634394core:PlantMachinery2023-10-3111634394core:Vehicles2023-10-3111634394core:FurnitureFittings2023-10-3111634394core:OfficeEquipment2023-10-3111634394core:AfterOneYear2023-10-3111634394core:WithinOneYear2023-10-3111634394core:ListedExchangeTraded2023-10-3111634394core:UnlistedNon-exchangeTraded2023-10-3111634394core:ShareCapital2023-10-3111634394core:SharePremium2023-10-3111634394core:RevaluationReserve2023-10-3111634394core:OtherReservesSubtotal2023-10-3111634394core:RetainedEarningsAccumulatedLosses2023-10-3111634394core:AfterOneYear2024-11-012025-10-3111634394core:WithinOneYear2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3111634394core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3111634394core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3111634394core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3111634394core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3111634394core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3111634394bus:Director12024-11-012025-10-3111634394bus:Director22024-11-012025-10-3111634394bus:Director32024-11-012025-10-3111634394bus:Director42024-11-012025-10-3111634394bus:Director52024-11-012025-10-3111634394bus:Director62024-11-012025-10-31

CONSILIUM SCIENTIFIC

Registered Number
11634394
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

CONSILIUM SCIENTIFIC
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

DILLON, Andrew, Sir
HUMPHREYS, Georgina Sarah, Dr
KAISER, Martin, Dr
LOW, Eric William
OSIPENKO, Elizaveta, Dr
WHITEHOUSE, Peter John, Prof

Registered Address

Mabledon Place
Hamilton House
London
WC1H 9BB

Registered Number

11634394 (England and Wales)
CONSILIUM SCIENTIFIC
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors3143,376105,918
Cash at bank and on hand354,0654,068
497,441109,986
Creditors amounts falling due within one year4(508,257)(120,802)
Net current assets (liabilities)(10,816)(10,816)
Total assets less current liabilities(10,816)(10,816)
Net assets(10,816)(10,816)
Capital and reserves
Profit and loss account(10,816)(10,816)
Reserves(10,816)(10,816)
The financial statements were approved and authorised for issue by the Board of Directors on 27 November 2025, and are signed on its behalf by:
OSIPENKO, Elizaveta, Dr
Director
Registered Company No. 11634394
CONSILIUM SCIENTIFIC
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by guarantee and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
2.Average number of employees

20252024
Average number of employees during the year11
3.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-102,514
Other debtors142,7722,966
Prepayments and accrued income604438
Total143,376105,918
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables25132,338
Other creditors2,99610,113
Accrued liabilities and deferred income505,01078,351
Total508,257120,802
5.Further information regarding the company's financial position
LIMITED BY GUARANTEE The company is limited by guarantee and has no share capital. Every member of the company undertakes to contribute to the assets of the company, in the event of winding up, such an amount as may be requested not exceeding £1.